XLRN - Acceleron: Neutral On Stock Price Gains April, 05 2021 09:43 PM Acceleron Pharma Inc. Acceleron’s stock price is near a 52-week high. Reblozyl sales are growing rapidly. While a favorite biotech for the long term, Acceleron is currently fairly priced. For further details see: Acceleron: Neutral On Stock Price Gains